Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Advanced Biotherapy prepares IND for corneal transplant rejection therapy

Dec. 11, 2002

Phase II Posurdex trial in persistent macular edema completes enrollment

Dec. 11, 2002

INS-37217, a P2Y2 receptor agonist, enhances subretinal fluid reabsorption in preclinical models

Dec. 3, 2002

Asahi Glass patents new prostaglandin analogues with utility in glaucoma Rx

Dec. 3, 2002

New ciclosporin prodrugs with utility in ocular disorders

Nov. 28, 2002

GenVec initiates phase I trial of AdPEDF in AMD

Nov. 28, 2002

Miravant discusses phase III SnET2 data with FDA

Nov. 27, 2002

Inspire plans to file INS-365 Ophthalmic NDA based on existing data

Oct. 31, 2002

Otsuka claims new adenosine A3 modulators and their use in glaucoma

Oct. 22, 2002

Clinical section of Vitrase NDA submitted

Oct. 14, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...